Only about one in four patients with unexplained, life-threatening arrhythmias are tested for cardiac sarcoidosis, even though medical guidelines…
Articles by Patricia Inácio, PhD
Treatment with rituximab can lead to meaningful improvements for some people with neurosarcoidosis affecting the brain and/or spinal…
The treatment of people with ocular sarcoidosis should be tailored based on symptom severity, starting with glucocorticoids. If…
Cutaneous sarcoidosis, a type of sarcoidosis of the skin, may increase the risk of certain blood cancers, a study…
Elevated blood levels of fatty molecules, or lipids — specifically triglycerides and low-density lipoprotein cholesterol (LDL-c), also known as bad…
A study shows therapeutic doses of Atyr Pharma’s experimental therapy efzofitimod were associated with a lower rate of…
Two early-career scientists each were awarded $150,000 Sarcoidosis Research Fellowship grants from the Foundation for Sarcoidosis Research (FSR) to…
Enrollment in aTyr Pharma’s pivotal Phase 3 EFZO-FIT clinical trial, testing the effectiveness and safety of efzofitimod in people with …
Microblading, a cosmetic technique that employs fine needles to deposit pigment to mimic the appearance of hairs, may be among…
A 37-year-old woman in Japan developed a granuloma — the clumps of cells that characterize sarcoidosis — in her…